Literature DB >> 11419427

Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.

D G Huntsman1, F Carneiro, F R Lewis, P M MacLeod, A Hayashi, K G Monaghan, R Maung, R Seruca, C E Jackson, C Caldas.   

Abstract

BACKGROUND: Germ-line truncating mutations in the E-cadherin (CDH1) gene have been found in families with hereditary diffuse gastric cancer. These families are characterized by a highly penetrant susceptibility to diffuse gastric cancer with an autosomal dominant pattern of inheritance, predominantly in young persons. We describe genetic screening, surgical management, and pathological findings in young persons with truncating mutations in CDH1 from two unrelated families with hereditary diffuse gastric cancer.
METHODS: Mutation-specific predictive genetic testing was performed by polymerase-chain-reaction amplification, followed by restriction-enzyme digestion and DNA sequencing in Family 1 and by heteroduplex analysis in Family 2. A total gastrectomy was performed prophylactically in five carriers of mutations who were between 22 and 40 years old. In each case, the entire mucosa of the stomach was extensively sampled for microscopical analysis.
RESULTS: Superficial infiltrates of malignant signet-ring cells were identified in the surgical samples from all five persons who underwent gastrectomy. These early diffuse gastric cancers were multifocal in three of the five cases, and in one person infiltrates of malignant signet-ring cells were present in 65 of the 140 tissue blocks analyzed, representing in aggregate less than 2 percent of the gastric mucosa.
CONCLUSIONS: We recommend genetic counseling and consideration of prophylactic gastrectomy in young, asymptomatic carriers of germ-line truncating CDH1 mutations who belong to families with highly penetrant hereditary diffuse gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11419427     DOI: 10.1056/NEJM200106213442504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  94 in total

Review 1.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

2.  Presumption, privilege, and preemption.

Authors:  Murray F Brennan
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

3.  DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy.

Authors:  Wen Quan Jonathan Goh; Ghim Siong Ow; Vladimir A Kuznetsov; Shirly Chong; Yoon Pin Lim
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 4.  [Prophylactic gastric surgery].

Authors:  H Vogelsang; K Ott; J Mehler; G Keller; J R Siewert
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

5.  To the editor: the role of prophylactic surgery in cancer prevention.

Authors:  Michael Fatouros; Georgios Baltogiannis
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

Review 6.  Hereditary diffuse gastric cancer: What the clinician should know.

Authors:  Ryan Ying Cong Tan; Joanne Ngeow
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

7.  Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.

Authors:  Jennifer Muir; Melyssa Aronson; Mary-Jane Esplen; Aaron Pollett; Carol J Swallow
Journal:  J Gastrointest Surg       Date:  2016-10-17       Impact factor: 3.452

8.  Individual having a parent with early-onset gastric cancer may need screening at younger age.

Authors:  Hee-Won Kwak; Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Soo-Jeong Cho; Bang Wool Eom; Hong Man Yoon; Jungnam Joo; Keun Won Ryu; Young-Woo Kim
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

9.  Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?

Authors:  D Shaw; V Blair; A Framp; P Harawira; M McLeod; P Guilford; S Parry; A Charlton; I Martin
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 10.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.